Statements (26)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
anabolic steroid
|
| gptkbp:administeredBy |
oral
|
| gptkbp:alsoKnownAs |
Methandrostenolone
|
| gptkbp:bannedIn |
gptkb:World_Anti-Doping_Agency
|
| gptkbp:chemicalFormula |
C20H28O2
|
| gptkbp:class |
gptkb:Schedule_III_controlled_substance_(US)
|
| gptkbp:countryOfOrigin |
gptkb:Switzerland
|
| gptkbp:developedBy |
gptkb:Ciba
|
| gptkbp:eliminationHalfLife |
3-6 hours
|
| https://www.w3.org/2000/01/rdf-schema#label |
Dianabol
|
| gptkbp:introducedIn |
1950s
|
| gptkbp:legalStatus |
illegal without prescription (US)
|
| gptkbp:marketedAs |
gptkb:Dianabol
D-bol |
| gptkbp:metabolism |
liver
|
| gptkbp:notableUser |
bodybuilders
|
| gptkbp:sideEffect |
hair loss
water retention high blood pressure acne liver toxicity gynecomastia |
| gptkbp:usedFor |
performance enhancement
muscle growth |
| gptkbp:bfsParent |
gptkb:methandrostenolone
|
| gptkbp:bfsLayer |
8
|